IMPROVING PARAMETER ESTIMATION FOR A DECISION-ANALYTIC MARKOV MODEL TO EVALUATE THE USE OF NOVEL BIOMARKER LED STRATEGIES FOR PREVETION OF CARDIOVASCULAR DISEASE